<DOC>
	<DOCNO>NCT02292069</DOCNO>
	<brief_summary>This study assess bioequivalence Amlodipine besylate/Atorvastatin calcium Tablets 10mg/80mg Dr. Reddy 's Laboratories Limited , India CADUETÂ® ( amlodipine besylate atorvastatin calcium ) tablets 10mg/80mg Pfizer Ireland Pharmaceuticals Dublin , Ireland healthy , adult , human subject Fed condition .</brief_summary>
	<brief_title>Bioavailability Study Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed Condition</brief_title>
	<detailed_description>Open label , randomize , two-treatment , two-period , two-sequence , oral bioequivalence study Amlodipine besylate/Atorvastatin calcium Tablets 10mg/80mg Fed condition .</detailed_description>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Amlodipine , atorvastatin drug combination</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>1 . Subjects age 18 45 year ( inclusive ) . 2 . Subjects ' weight within normal range accord normal value Body Mass Index ( 18.5 24.9 kg/m2 ) minimum 50 kg weight . 3 . Subjects normal health determine personal medical history , clinical examination laboratory examination within clinically acceptable reference range . 4 . Subjects normal 12lead electrocardiogram ( ECG ) . 5 . Subjects normal chest XRay ( P/A view ) whose XRay take 6 month prior dose Period 01 . 6 . Subjects negative urine screen drug abuse ( include amphetamine , barbiturate , benzodiazepine , marijuana , cocaine , morphine ) . 7 . Subjects negative alcohol breath test . 8 . Subjects willing adhere protocol requirement provide write informed consent . 1 . Hypersensitivity Amlodipine Atorvastatin related class drug . 2 . History presence significant cardiovascular , pulmonary , hepatic , renal , gastrointestinal , endocrine , immunological , dermatological , neurological psychiatric disease disorder . 3 . Any treatment could bring induction inhibition hepatic microsomal enzyme system within 1 month study start . 4 . History presence significant alcoholism drug abuse . 5 . History presence significant smoking ( 10 cigarette beedi's/day ) . 6 . History presence asthma , urticaria significant allergic reaction . 7 . History presence significant gastric and/or duodenal ulceration . 8 . History presence significant thyroid disease , adrenal dysfunction , organic intracranial lesion pituitary tumor . 9 . History presence cancer . 10 . Difficulty donate blood . 11 . Difficulty swallow solid like tablet capsule . 12 . Use prescribed OTC medication last two week prior dose period 01 . 13 . Major illness 3 month screen . 14 . Participation drug research study within past 3 month . 15 . Donation blood past 3 month screen . 16 . Consumption grapefruit juice , xanthinecontaining product , tobacco containing product alcohol within 48 hour prior dose . 17 . Positive screen test one : HIV , Hepatitis B Hepatitis C. 18 . History presence significant easy bruise bleeding . 19 . History presence significant recent trauma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>